Distinguished leaders from fields including healthcare, law, entertainment, hospitality, and more make up our Board of Directors. While diverse in their areas of expertise, all of our members are united in their passion to advance ovarian and related gynecologic cancer research, help guide our path forward, and contribute toward our goal of finding a cure.
After months of dedicated advocacy alongside survivors, families, and clinicians, the bipartisan Ovarian Cancer Improving and Modernizing Prevention, Access, Care, and Testing (IMPACT) Act has officially been introduced in Congress. Championed by Senators Elissa Slotkin (D-MI) and Katie Britt (R-AL) in the Senate, and Representatives Rosa DeLauro (D-CT-03) and Don Bacon (R-NE-01) in the House, this bill … Continued
Dear Friends, Every day, I’m reminded that this community doesn’t wait for change—it builds it, together. That’s true across everything OCRA does, and it’s true of the impact we have made, with your help, through our September fundraising campaign. Because so many of you have stepped forward, we’ve extended our goal to $350,000. Every gift … Continued
Watch expert sessions on ovarian, endometrial, cervical, and rare gynecologic cancers, and more This September, more than 2,180 people from 65 countries came together for OCRA’s 2026 International Gynecologic Cancer Conference® to learn the latest updates, gain resources for navigating gynecologic cancer, and find support, community, and hope. If you couldn’t join us live, or … Continued
Get email updates about research news, action alerts, and ways to join the fight.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
